A prospective characterization of 62 young males with genetically confirmed MECP2 duplication syndrome has identified profound developmental delays across all assessed functional domains, with median age-equivalent scores failing to surpass 20 months despite chronological ages reaching up to 15 years. Published in the Journal of Neurodevelopmental Disorders, the study represents one of the largest standardized assessments to date of adaptive and developmental progression in this rare, X-linked condition. The clinical disorder is classically defined by severe-to-profound intellectual disability, limited-to-absent speech, epilepsy, and comprehensive global functional dependence, making day-to-day functional capacity a primary concern for caregivers.
To establish baseline outcomes and track trajectories ahead of forthcoming clinical trials for investigational therapies, researchers aggregated longitudinal and cross-sectional data collected at a single center. The cohort was restricted to male patients under 18 years of age whose diagnoses were confirmed through genetic testing. Investigators evaluated developmental outcomes using three standardized, trial-ready assessment batteries: the Vineland Adaptive Behavior Scales, Second Edition (VABS-II); the Bayley Scales of Infant and Toddler Development, Third Edition (BSID-III); and the community version of the Aberrant Behavior Checklist (ABC-C).
Detailed cross-sectional analysis across age bins demonstrated notable variation among specific skill domains despite the presence of overarching developmental delays. Receptive communication abilities emerged as a relative strength within the cohort’s functional profiles. Conversely, marked weaknesses were documented in expressive language, interpersonal relationship development, and gross motor performance. Motor limitations were especially pronounced across the patient sample, with not a single child attaining a gross motor functional level exceeding that of a typically developing 24-month-old infant.
Longitudinal tracking of the cohort captured an eventual plateau in developmental skill acquisition over time. Modest gains in adaptive functioning were observed primarily during early childhood and were largely concentrated within the pre-epileptic subgroup of participants. The onset and presence of epilepsy served as a major clinical modifier, linked to substantially poorer functional outcomes. Specifically, individuals with epilepsy exhibited markedly lower functional performance, including an average reduction of nine months in gross motor ability, as well as heightened levels of lethargy.
Behavioral patterns examined through the Aberrant Behavior Checklist indicated prominent expressions of social withdrawal alongside modest levels of repetitive behaviors. The data also suggested an association between functional status and behavioral manifestation, whereby relatively higher levels of adaptive functioning were correlated with higher levels of externalizing behaviors. Concurrently, the study established that scores on the caregiver-administered VABS-II were well-correlated with direct, clinician-administered BSID-III performance measures, indicating that caregiver reports provide a dependable proxy for assessing true developmental abilities in this population.
The documented trajectories provide critical quantitative parameters for the design and interpretation of future interventional clinical trials in MECP2 duplication syndrome. Under natural disease progression, a group-mean improvement of three or more raw score points on any VABS-II subdomain would be largely unexpected over an observation period of 12 to 18 months. For individuals diagnosed with both the syndrome and active epilepsy, the authors conclude that halting disease progression or achieving stabilization of VABS-II scores over a 12-to-18-month timeframe could itself represent meaningful clinical benefit for evaluating potential supportive and adjunctive therapies.
By evaluating functional trajectories across age bins alongside longitudinal changes, the study establishes standardized reference data as investigational therapies prepare to enter the clinic. Characterizing how developmental skills evolve over time documents an eventual plateau in skill acquisition, demonstrating that developmental gains remain modest and occur primarily during early childhood. Defining these developmental profiles and tracking functional progression with standardized instruments addresses chief caregiver concerns and provides essential parameters for interpreting functional stability or change in future clinical trials.
The strong agreement between caregiver-reported VABS-II scores and direct BSID-III performance measures confirms that caregiver assessments serve as a dependable proxy for direct developmental evaluation. In addition to measuring developmental skills, capturing behavioral profiles through the ABC-C highlights the co-occurrence of social withdrawal, modest repetitive behaviors, and externalizing tendencies in individuals with relatively higher functioning. Together, these standardized observations define key clinical modifiers and behavioral characteristics in MECP2 duplication syndrome, providing essential baseline data to inform the evaluation of supportive and adjunctive therapies.
Subject of Research: Developmental trajectories and adaptive functioning in MECP2 duplication syndrome
Article Title: Developmental skills and adaptive functioning in MECP2 duplication syndrome
Article References: Peters, S. U., Malik, P. R., Lyu, F., Fu, C., Neul, J. L., & Coquery, C. (2026). Developmental skills and adaptive functioning in MECP2 duplication syndrome. Journal of Neurodevelopmental Disorders. https://doi.org/10.1186/s11689-026-09723-y
Image Credits: AI Generated
DOI: 10.1186/s11689-026-09723-y
Keywords: MECP2 duplication syndrome, adaptive functioning, developmental delay, pediatric neurology, neurodevelopmental disorders, epilepsy, gross motor skills, receptive communication, expressive language, Vineland Adaptive Behavior Scales, Bayley Scales of Infant and Toddler Development, Aberrant Behavior Checklist, intellectual disability, caregiver report, clinical trial endpoints, social withdrawal
News Source: Kendall Mcintyre. (November 18, 2026). Epilepsy Marks Lower Adaptive Functioning in Boys With MECP2 Duplication Syndrome. Scienmag.



